<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type II SH2 domain-containing <z:chebi fb="1" ids="24848">inositol</z:chebi> 5-phosphatase (INPPL1, or SHIP2) plays an important role in the control of insulin sensitivity </plain></SENT>
<SENT sid="1" pm="."><plain>INPPL1 mutations affecting gene function have been found in rat models of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> and in type 2 diabetic patients </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the influence of nucleotide variation in INPPL1 on components of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Following comprehensive resequencing of the gene, we genotyped 12 informative polymorphisms in 1,304 individuals from 424 British type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> families that were characterized for several metabolic phenotypes </plain></SENT>
<SENT sid="4" pm="."><plain>We have found highly significant associations of single nucleotide polymorphisms (SNPs) and haplotypes of INPPL1 with <z:hpo ids='HP_0000822'>hypertension</z:hpo> as well as with other components of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In a cohort of 905 French type 2 diabetic patients, we found evidence of association of INPPL1 SNPs with the presence of <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that INPPL1 variants may impact susceptibility to disease and/or to subphenotypes involved in the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in some diabetic patients </plain></SENT>
</text></document>